Eka Funding
Book a demo
AstraZeneca India Gains CDSCO Nod to Import Lifesaving Drug Soliris
AstraZeneca Pharma India has received approval from the Central Drugs Standard Control Organisation (CDSCO) to import Eculizumab (Soliris) Concentrate for Solution for Infusion 300 mg (10 mg/ml). This breakthrough drug targets two critical and rare conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH) & Atypical Hemolytic Uremic Syndrome (aHUS)
on
January 20, 2025
Samsung and Eka Care Bring Digital Health Revolution to Your Fingertips
Samsung, in partnership with Eka Care, has launched a breakthrough Health Records feature on the Samsung Health app, enabling seamless and secure management of personal health data. The feature is aligned with the Indian government’s Ayushman Bharat Digital Mission (ABDM) and aims to streamline health record access for both users and healthcare professionals.
on
January 18, 2025
Non-Invasive Device for Diabetes Monitoring Unveiled by BITS Pilani-Hyderabad
Researchers at BITS Pilani, Hyderabad, have unveiled an innovative Machine Learning (ML)-assisted non-invasive portable device for diabetes detection and management. This groundbreaking solution eliminates the need for finger-pricking by using sweat or urine to monitor critical biomarkers such as glucose, lactate, uric acid, and hydrogen peroxide.
on
January 19, 2025
Breaking: Suspected Marburg Virus Outbreak in Tanzania – WHO Issues Alert
Nine suspected cases of Marburg Virus Disease (MVD), including eight deaths, were reported in Tanzania’s Kagera region. The outbreak spans two districts—Biharamulo and Muleba—and presents a high case fatality rate (CFR) of 89%. WHO has issued a rapid alert to its Member States, highlighting the urgent need for enhanced surveillance and medical response.
on
January 16, 2025
Lancet Redefines Obesity: Beyond BMI, A New Medical Perspective
The Lancet Commission on Clinical Obesity has proposed groundbreaking changes to the way obesity is defined and diagnosed, marking a shift from traditional BMI measurements to a more nuanced approach that considers fat distribution and organ function. The report, endorsed by 76 organizations and 58 global experts, introduces two new diagnostic categories: clinical obesity and preclinical obesity, aiming to provide personalized care and reduce stigma.
on
January 15, 2025
Previous
Next
Featured
FDA Approves Blujepa (Gepotidacin): First New Oral Antibiotic for uUTIs in Nearly 30 Years
Lorundrostat Shows Promise in Treating Uncontrolled Hypertension in Pivotal Trials
Kerala School Reports Viral Meningitis Cases, Health Authorities on High Alert
DCGI’s Renewed Mandate: Wiping Out Substandard Drugs, Supporting MSMEs, and Regulating Medical Devices
Delhi Sees Surge in H1N1 and Influenza B Cases
Participate in India’s healthcare revolution
Create ABHA & store all your medical records with Eka care (Govt of India ABDM approved PHR app)
Create ABHA ID
Popular topics
#
newfeature
#
Partnership
#
funding